Aarti Drugs is currently trading at Rs. 562.20, up by 21.85 points or 4.04% from its previous closing of Rs. 540.35 on the BSE.
The scrip opened at Rs. 541.00 and has touched a high and low of Rs. 575.00 and Rs. 541.00 respectively. So far 10499 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 575.00 on 07-July-2014 and a 52 week low of Rs. 165.00 on 24-Sep-2013.
Last one week high and low of the scrip stood at Rs. 575.00 and Rs. 526.00 respectively. The current market cap of the company is Rs. 679.29 crore.
The promoters holding in the company stood at 59.61% while Institutions and Non-Institutions held 0.01% and 40.37% respectively.
Aarti Drugs is planning to acquire an undertaking/Company at Baddi in Himachal Pradesh to cater its existing business of Toll manufacturing of formulations as an initiative to have its own facilities for this business subject to necessary diligences and approval processes. Board of Directors of the Company at its meeting held on July 07, 2014, has considered the same.
Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.
